Erich Koller
Basel, BS 4070, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Angelman syndrome patient-derived neuron screen leads to clinical ASO rugonersen targeting UBE3A-ATS with long-lasting effect in monkeys.
Journal: Nucleic acids research
Published: February 10, 2025
A CRISPR/Cas9 screen reveals proteins at the endosome-Golgi interface that modulate cellular anti-sense oligonucleotide activity.
Journal: Nature communications
Published: January 09, 2025
Improved targeted delivery of antisense oligonucleotide with an antibody mask.
Journal: Nucleic acids research
Published: August 08, 2024
Diligent Design Enables Antibody-ASO Conjugates with Optimal Pharmacokinetic Properties.
Journal: Bioconjugate chemistry
Published: November 02, 2023
Investigating discovery strategies and pharmacological properties of stereodefined phosphorodithioate LNA gapmers.
Journal: Molecular therapy. Nucleic acids
Published: January 14, 2022
Translating pharmacology models effectively to predict therapeutic benefit.
Journal: Drug discovery today
Published: November 08, 2021
Safety, Tissue Distribution, and Metabolism of LNA-Containing Antisense Oligonucleotides in Rats.
Journal: Toxicologic pathology
Published: June 01, 2021
Evaluation of bovine milk extracellular vesicles for the delivery of locked nucleic acid antisense oligonucleotides.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: August 21, 2020
Studying the Biotransformation of Phosphorothioate-Containing Oligonucleotide Drugs by LC-MS.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: August 15, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026